Monzo boss was ‘pushed out’ over IPO dispute Fintech The boss of digital bank Monzo is said to have been pushed out from the top role following a dispute with the company’s board over a potential stock market listing. TS Anil, Monzo’s chief executive of the last five years, is said to have been at odds with the fintech’s board ahead of his surprise [...]
Bank of England Live: Bailey refuses to confirm if Budget influenced rates decision Markets Welcome back to the City AM liveblog. Andrew Bailey has refused to confirm whether the upcoming Budget and Rachel Reeves’ recent comments influenced his decision on interest rates. The Bank of England has held interest rates at four per cent in its final decision before the Autumn Budget. The Bank’s Monetary Policy Committee (MPC) voted [...]
High energy prices make the UK ‘vulnerable’ US ambassador warns Business The US ambassador to the UK has warned Britain’s sky-high energy prices threaten to undermine its status as a major global economy. Speaking at an event at the Savoy Hotel on Wednesday, Warren Stephens described UK energy prices, which are among the highest in the world, as the “chief obstacle” to growth. “Energy costs in [...]
Astrazeneca to ‘upgrade’ US listing in latest blow to London Stock Exchange September 29, 2025 Astrazeneca has laid out plans aimed at “upgrading” its US listing in the latest blow to the London Stock Exchange. The Cambridge-based pharma giant said it would replace its existing Nasdaq listing of American Depositary Receipts (ADRs), a type of listing for trading overseas shares, with a direct listing of ordinary shares on the New [...]
GSK shares rally as chief Emma Walmsley to exit after eight years September 29, 2025 The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at the end of the year. Emma Walmsley, who took the helm of the drugmaker in 2017, will be replaced by chief commercial officer Luke Miels. Miels – the former Executive Vice President of Astrazeneca – also joined the [...]
Week in Business: Businesses flee high-tax Britain September 11, 2025 On the same day that Reeves said "there's no growth without investment", a pharma giant pulled its £1bn London investment plans.
Losing AstraZeneca would be more than a bitter pill for the City – it could be fatal July 2, 2025 The government must urgently scrap stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange losing its most valuable listing, Astrazeneca, says Michael Healy The UK stock market just received its biggest wake-up call yet. Reports that Astrazeneca – the most valuable company on the London Stock Exchange – is [...]
Astrazeneca chief ‘wants to shift London listing to US’ July 1, 2025 The boss of Britain’s most valuable company, Astrazeneca, has reportedly voiced his preference to move the firm’s stock market listing to the United States. Sir Pascal Soriot, who has been at the helm of the pharma juggernaut since 2012, is said to have spoken privately about his desire to abandon the UK listing in favour [...]
London Tech Week: Astrazeneca’s AI push could take humans out of the loop June 10, 2025 Astrazeneca unveiled an ambitious overhaul of its manufacturing and supply operations driven by deep tech, AI, and what it called a “self-healing” supply chain at London Tech Week. The firm claimed it’s laying the groundwork to become one of the top 10 most innovative and sustainable supply chains globally by 2030. But while the vision [...]
GSK shares rise as FTSE 100 giant ‘well positioned’ for pharma tariffs April 30, 2025 British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread speculation President Donald Trump is set to target pharmaceutical imports with his tariff agenda. Trump voiced his desire to slap tariffs on pharma products in the “not too distant future”. He previously said: “We don’t make our [...]